ZEOXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Zeo ScientifiX, Inc.
Financials through Q2 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Jun 15, 2026
$0.91+0.00 (+0.15%)
Close on Oct 19, 2026
- Market cap
- $7.08M
- P/E (TTM)
- –
- Dividend yield
- –
Zeo ScientifiX statistics
Financials through Apr 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Zeo ScientifiX | Industry median |
|---|---|---|
| Market Cap | $7.15M | $166.30M |
| Enterprise Value | $5.55M | $87.12M |
| PS Ratio | 1.02 | 3.60 |
| PB Ratio | 10.04 | 2.03 |
| P/TBV Ratio | 10.04 | 2.31 |
Enterprise value
| Measure | Zeo ScientifiX | Industry median |
|---|---|---|
| EV / Sales | 0.79 | 2.43 |
Income (trailing twelve months)
| Measure | Zeo ScientifiX | Industry median |
|---|---|---|
| Revenue | $6.99M | $57.94M |
| Gross Profit | $5.70M | $90.47M |
| Operating Income | -$4.13M | -$21.49M |
| Net Income | -$3.88M | -$22.46M |
| EBITDA | -$4.05M | -$17.14M |
| EPS (Diluted) | -$0.58 | -$0.83 |
Margins
| Measure | Zeo ScientifiX | Industry median |
|---|---|---|
| Gross Margin | 81.5% | 52.3% |
| Operating Margin | -59.1% | -44.5% |
| Profit Margin | -55.6% | -39.2% |
| EBITDA Margin | -58.0% | -31.3% |
Returns
| Measure | Zeo ScientifiX | Industry median |
|---|---|---|
| Return on Assets (ROA) | -146.0% | -41.0% |
| Return on Capital Employed (ROCE) | -532.8% | -38.0% |
Growth
| Measure | Zeo ScientifiX | Industry median |
|---|---|---|
| Revenue Growth (3Y CAGR) | -7.13% | 2.25% |
| Revenue Growth (5Y CAGR) | 11.2% | 6.42% |
Balance sheet
| Measure | Zeo ScientifiX | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.85M | $62.64M |
| Total Debt | $247.00K | $120.13M |
| Net Cash (Debt) | $1.60M | $15.77M |
| Net Cash Per Share | $0.20 | $0.66 |
| Equity (Book Value) | $712.00K | $48.61M |
| Book Value Per Share | $0.09 | $1.36 |
| Tangible Book Value | $712.00K | $23.01M |
| Working Capital | $155.00K | $75.09M |
Financial position
| Measure | Zeo ScientifiX | Industry median |
|---|---|---|
| Current Ratio | 1.05 | 3.30 |
| Quick Ratio | 0.68 | 2.39 |
| Debt / Equity | 0.35 | 0.51 |
| Interest Coverage | -54.33 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Zeo ScientifiX | Industry median |
|---|---|---|
| Operating Cash Flow | -$1.25M | -$12.39M |
Efficiency
| Measure | Zeo ScientifiX | Industry median |
|---|---|---|
| Asset Turnover | 2.63 | 0.38 |
| Inventory Turnover | 2.80 | 2.67 |
| Revenue Per Employee | $211.73K | $398.96K |
| Profits Per Employee | -$117.70K | -$705.27K |
| Employee Count | 33 | 74 |
Dividends and yields
| Measure | Zeo ScientifiX | Industry median |
|---|---|---|
| Earnings Yield | -54.3% | -22.8% |
Shares
| Measure | Zeo ScientifiX | Industry median |
|---|---|---|
| Shares Outstanding | 7,837,440 | 58,139,000 |
| Shares Change (QoQ) | 2.27% | 0.54% |
| Float | 1,027,200 | 49,154,900 |
| Shares Held by Insiders | 86.9% | 11.6% |
Scores
| Measure | Zeo ScientifiX | Industry median |
|---|---|---|
| Altman Z-Score | -25.07 | -0.27 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Zeo ScientifiX's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.